prescription-appropriateness-review

Geriatric prescription review applies AGS 2023 Beers Criteria, STOPP/START rules, and renal/hepatic dosing to active medications and diagnoses, generating a structured safety report with flagged items and deprescribing recommendations.

STOPP/START assessment identifies potentially inappropriate medications and prescribing omissions in elderly patients by evaluating active diagnoses and medications against evidence-based criteria to produce actionable optimization steps.

Renal and hepatic dosing adjustments are calculated using patient eGFR and liver function labs to modify or deprescribe medications, ensuring geriatric prescription safety reviews include accurate pharmacokinetic considerations.

Identifying PPI overuse and inappropriate medications involves applying AGS 2023 Beers Criteria and STOPP/START rules to active medication lists, returning a structured report with deprescribing suggestions and monitoring plans.

A comprehensive geriatric medication safety review requires patient demographics, active medications, active diagnoses, and renal/hepatic lab values to apply Beers Criteria and STOPP/START rules accurately.

Geriatric prescription review outputs a structured report containing flagged inappropriate medications, suggested deprescribing steps, safer alternatives, and specific monitoring plans based on Beers Criteria and STOPP/START evaluation.